ABSTRACT Previously, we reported a genome wide association study (GWAS) that had shown association of a region between 11.8 and 13.6 Mbp on chromosome 9 with ascites phenotype in broilers. We had used microsatellite loci to demonstrate an association of particular genotypes for this region with ascites in experimental ascites lines and commercial broiler breeder lines. We identified two potential candidate genes, AGTR1 and UTS2D, within that chromosomal region for mediating the quantitative effect. We have now extended our analysis using SNPs for these genes to assess association with resistance or susceptibility to ascites in these same broiler lines. Surprisingly, in contrast to our previous GWAS and microsatellite data for this region, we find no association of the SNP genotypes or haplotypes in the region suggesting that the two genes might have limited association with the disease phenotype.
INTRODUCTION
Idiopathic pulmonary arteriole hypertension (IPAH) in humans is a disease characterized by progressive pulmonary vascular remodeling that results in rightventricular hypertrophy (RVH), right-ventricular failure, and premature death (Hoeper et al., 2007) . In the chicken industry, IPAH is commonly referred to as ascites. Chickens develop hypertension resulting in right ventricular hypertrophy, which results in leakage of fluids from the liver and organs accumulating in the peritoneal cavity producing a "water belly" (Julian, 1993) . Most studies have indicated ascites to be a complex polygenic trait with significant genotypic and phenotypic variability between ascites resistant and susceptible chickens (de Greef et al., 2001; Moghadam et al., 2001; Pakdel et al., 2005; Rabie et al., 2005; Druyan and Cahner, 2007; Hamal et al., 2010a,b) . Ascites has also been reported to have moderate to high heritability (Lubritz and McPherson, 1994; Lubritz et al., 1995; French, 1999, 2000; Pakdel et al., 2005; Druyan and Cahner, 2007; Pavlidis et al., 2007) .
Pathogenesis of ascites syndrome in chickens has been attributed to a number of environmental, nutritional, physiological, and genetic factors (Julian, 1993; C Balog, 2003; Baghbanzadeh and DeCuypere, 2008) . Lungs in chickens, being rigid and fixed with the thoracic cavity, do not expand with increased airflow during respiration. Hence, in healthy birds, the pulmonary circulatory system maintains a low blood flow resistance, and operates at low hydrostatic pressures in order to prevent fluid accumulation in the alveoli that would otherwise give rise to pulmonary edema (Wideman et al., 2013) . However, in fast-growing broilers, due to increased demands of oxygen in the body, the pulmonary vascular channels remain engorged with deoxygenated blood increasing the pressure in the right ventricle, and thereby causing right ventricular hypertrophy (elevated right to total ventricular ratios; RV:TV ratios). Because of the increasing pressure, the right ventricle's enhanced cardiac output results in rapid blood flow through the lungs. The increased flow of blood through the lungs compromises complete diffusive exchange of oxygen (O 2 ) and carbon dioxide (CO 2 ) in the alveoli. As a result, the blood leaving the lungs has a lower partial pressure of the O 2 (hypoxemia) and higher partial pressure of CO 2 (hypercapnia). Iterative cycles of hypoxemic blood circulation through the lungs of healthy, fast growing broilers induce a cascade of events, primarily causing pulmonary vasoconstriction, increased vascular resistance, pulmonary hypertension, liver congestion, leakage of fluids in the lungs (edema), peritoneum, and abdomen of the birds (ascites) finally triggering right ventricular failure (Wideman et al., 2007 (Wideman et al., , 2013 .
788
Hypoxia (low partial pressure of O 2 in the blood) has been shown to be one of the major factors responsible for acute pulmonary vasoconstriction and pulmonary hypertension in broilers (Peacock et al., 1989; RuizFeria and Wideman Jr., 2001) . Increase in altitude (accompanied by reduced levels of O 2 ) generates hypoxic conditions. Taking advantage of this, researchers at the University of Arkansas used high altitude simulation in a hypobaric chamber (creating hypoxic conditions), and sib-selection, to establish divergently selected lines derived from a former full-pedigreed elite line of the 1990s, which includes an ascites resistant (RES) line, ascites susceptible (SUS) line, and a relaxed (REL) unselected line (Pavlidis et al., 2007; Wideman et al., 2013) . Previously, we used a low coverage (3,700 SNP; Muir et al., 2008) genome wide SNP association panel to examine 183 offspring from an F2 reciprocal cross of the SUS and RES lines to identify an association of the 11.8 to 13.9 Mbp region on chromosome 9 (Gga9) with ascites (Krishnamoorthy et al., 2014) . Two microsatellite loci from this region demonstrated femalespecific association of particular genotypes with ascites susceptibility for both the experimental RES and SUS lines and for two of the three modern commercial elite broiler lines. Within the associated region shown in the genome wide association study (GWAS), we identified two candidate genes, AGTR1 and UTS2D, as possible mediators of ascites susceptibility.
The renin-angiotensin system (RAS) pathway plays a vital role in developmental processes and organogenesis of the heart and kidney (Wolf and Neilson, 1993; Price et al, 1997) . RAS also regulates the pathophysiology of hypertension, cardiac hypertrophy and vascular diseases (Kometiani et al., 1998; Palatini et al., 2009) . Angiotensin II (AngII) hormone is a key regulator of the RAS pathway, and plays an important role in systemic vascular remodeling, blood pressure control and cardiovascular homeostasis (Pousada et al., 2015) . AngII binds to two G-coupled receptor subtypes-AngII type 1 receptor (AGTR1) and AngII type 2 receptor (AGTR2), which act antagonistically to regulate the RAS endocrine pathway (Greindling et al., 1996) . Signaling through AGTR1 has both cardiac and systemic effects, and is known to trigger vasoconstriction, cellular hypertrophy, and catecholamine release; whereas AGTR2 inhibits vasoconstriction, cellular hypertrophy and catecholamine release (Palatini et al., 2009; Cuffe et al., 2014) . Increased levels of AGTR1 have also been suggested to have shown vasotonic and hypoxic responses, as well as distal muscularization in pulmonary vessels (Chassagne et al., 2000; Pousada et al., 2015) . Polymorphisms of AGTR1 have been associated with diastolic heart failure in humans (Wu et al., 2009) .
UTS2D belongs to the urotensin II family, along with urotensin 2 (UTS2) and urotensin 2 receptor (UTS2R) (Douglas et al., 2004) . UTS2 is a potent vasoconstrictive peptide that plays a role in modulating both endothelial independent as well as dependent vasodilation (Ong et al., 2008) . Elevated plasma levels of the peptide are also associated with susceptibility to diabetes, renal failure, hypertension, congestive heart failure, and carotid atherosclerosis (Ong et al., 2008) . UTS2D is the endogenous and functional ligand of UTS2, which binds and activates the peptide (Jiang et al., 2008) .
As discussed earlier, healthy chickens are predisposed to ascites when alveolar hypoxia takes place. In fast-growing broilers, hypoxia may arise due to abnormal ventilation/perfusion (V/Q) ratio (Balog, 2003) . A decrease in the V/Q ratio takes place when ventilation is low and perfusion of deoxygenated blood is high, resulting in inadequate CO 2 /O 2 exchange in the lungs. In high altitude conditions, low partial pressure of O 2 results in an increase in physiological dead space within the bird's parabronchi, which further aggravates the hypoxic situation. Chronic hypoxia is a major contributor to vasoconstriction, pulmonary vasculature remodeling, increased vascular resistance, and right ventricular hypertrophy (Peacock et al., 1989; Karamsetty et al., 1995; Wideman et al., 1997; Raj and Shimoda, 2002) . Therefore, given the roles of AGTR1 and UTS2D in hypoxia and vasoconstriction, the two genes are strong candidates for the heritable, polygenic trait of ascites.
The objectives of our current study were to develop SNP assays for the gene regions of AGTR1 and UTS2D to examine trait association of these candidate genes to better comprehend the molecular basis of resistance/susceptibility and gender bias for ascites phenotype.
MATERIALS AND METHODS

Genomic Data
All genome positions indicated in this report are according to the November 2011 assembly of the Gallus gallus genome GenBank accession ID: GCA 000002315.2. Genomic sequences for specific chromosomal regions or genes were downloaded using the UCSC genome browser (http://genome.ucsc.edu).
Genomic DNAs
DNAs isolated from chicken blood were those described in our previous report (Bailes et al., 2007; Krishnamoorthy et al., 2014) .
PCR Sequencing
PCR primers to amplify targeted gene regions were designed using , then synthesized by Integrated DNA Technologies (IDT; Coralville, IA). PCR conditions were optimized for each primer pair, and then used to amplify the region from multiple individual DNAs from the RES and SUS lines. Quality of PCR products were evaluated on agarose gels, purified using RapidTip functional pipette tips (Diffinity Table 1 . Primers, probes, and conditions for qPCR. For each SNP locus: position is the base-pair position on chromosome 9 according to the 2011 genome assembly; Primers are 5 -3 for forward (F-) and reverse (R-); Probes are 5 -3 with allele 1 (P1) labeled with FAM and allele 2 (P2) labeled with HEX; and the soak temperature (
• C) used in the qPCR assay. 
SNP Genotyping
Primers and probes developed for exonuclease assays for particular SNPs are listed in Table 1 . Probes incorporating Zen modifications quenched with Iowa Black were obtained from IDT. SNP genotypes were determined by quantitative-PCR (qPCR) in 96 well plates using a CFX96 real-time thermocycler (Bio-Rad Laboratories, Inc., Hercules, CA). Each 20 μL reaction consisted of 1X Taq Buffer (50 mM Tris-Cl, pH 8.3, 1 mM MgCl 2 , 30 μg/mL of BSA), 0.25 mM MgCl 2 , 0.2 mM dNTP, 0.5 μM each of the specific forward and reverse primers, 0.25 μM each of the two probes, 4 units of Taq polymerase, and 2 μL of DNA (50 to 100 ng). Cycle parameters were 90
• C for 30 s, 10 cycles of 90 • C for 15 s, and primer-specific soak for 30 s (Table 1) , followed by 30 cycles of 90
• C for 15 s, primer-specific soak for 30 s (Table 1) , and plate read.
Statistical Methods
Analysis of genotype and allelic distributions was performed using Microsoft Excel (Microsoft Corporation, Redmond, WA). Single nucleotide polymorphism loci for each chicken line was evaluated for deviation from Hardy-Weinberg (HW) Equilibrium using the CHITEST function comparing observed counts with the computed expected counts based on allele frequencies for the line. Genotype data for dead birds with inconclusive necropsy for ascites were included, however, those genotypes were excluded from computations in resistant and susceptible subpopulations. HW equation (1 = p 2 +2pq+q 2 ) was used to calculate the expected genotype counts. To combine loci, we imputed haplotypes where either or both of the loci were homozygous. Haplotype frequencies for the entire population were used to calculate the expected haplotype counts for resistant and susceptible subpopulations. Observed counts for resistant and susceptible subpopulations were compared to expected counts using the CHITEST function of MS Excel to compute P-values for each genotype or haplotype. P-values were determined only for those genotypes or haplotypes that occurred at ≥10%. A simple Bonferroni correction was used to generate adjusted Pvalues, by multiplying each calculated P-value by the number of calculated P-values for that locus analysis. Statistical significance was defined as adjusted P-value of <0.05.
Linkage disequilibrium (LD) between microsatellite and SNP markers was measured using Lewontin's normalized disequilibrium co-efficient D' (Lewontin, 1964) modified for multiple alleles (Hedrick, 1987) . For two allele loci, Lewontin's standardized measure is calculated as
x ij is the frequency of haplotypes with allele i at the first marker locus and allele j at the second marker locus; p i and q j are the allele frequencies at the first and second marker loci, respectively. With multiple alleles at the two loci, the disequilibrium between the two markers is measured as
where k and l are the number of alleles at the first and second marker loci.
RESULTS
Our previously reported GWAS and variable number tandem repeat (VNTR) study had demonstrated significant association of Gga9 from the 11.8 to 13.6 Mbp region (2011 genome assembly coordinates) with ascites in our ascites research lines and two of the three selected commercial broiler elite lines (Krishnamoorthy et al., 2014) . The study also Table 2 . SNPs identified in the UTS2D promoter and intron 3 from SUS and RES chickens, Jungle fowl (JF) and White Leghorn (WL). For the UTS2D promoter, the SNP chromosomal locations (bp) are: 13,177,222, 13,177,287, 13,177,384, 13,177,418, 13,177,419, 13,177,463, 13,177,470, 13,177,470, 13,177,542, 13,177,951, and 13,178,095 , respectively. For the UTS2D intron 3, the locations are: 13,182,464, 13,182,520-13,182,522, 13,182,532, 13,182,569, 13,182,575, 13,182,646, 13,182,659, 13,182,677, 13,182,693, 13,182,808, 13,182,872, 13,182,905, 13,182,916, and 13,182,943, 
identified two candidate genes, AGTR1 (Gga9: 11,859,037-11,880,012 bp) and UTS2D (Gga9: 13,178,354-13,185,135 bp), within this region as possible mediators of this quantitative trait. In order to further validate any role for these genes we used PCR sequencing of selected regions of these genes to identify SNPs that are segregating in our divergently selected lines. For AGTR1 we had previously sequenced all three exons along with some flanking intronic sequences (Burks, 2011) . For UTS2D, we sequenced two specific non-coding sequences to identify SNPs for further genotype analyses. We chose to target the promoter (1,191 bases upstream of exon 1) to possibly identify SNPs in transcription factor binding sites, and intron 3 (1,945 bases), which was short enough for PCR amplification using exonic primers and would be more variable than exonic sequences. We then chose individual SNPs, or clusters of SNPs, for development of exonuclease qPCR tests (TaqMan assays) for additional association studies. SNP targets included a span of 5 SNPs within 11 bases in intron 1 of AGTR1, a single SNP upstream of exon 1 for UTS2D, a pair of SNPs in intron 3 of UTS2D, and a single base SNP at 13,193,937 bp (Table 1) . Reasons for selecting these particular SNPs are as follows.
UTS2D intron 3 sequences from six RES and nine SUS samples identified 15 SNPs defining as many as six potential haplotypes ( Table 2 ). The exonuclease assay we developed (UTS2Di3, Table 1) targeted two SNPs (GAG vs. TAA) early in intron 3. We targeted these two SNPs because our sequence data suggested there were only two alleles that were segregating in both RES and SUS (with different apparent frequencies, Table 2 ), and a pair of SNPs would provide better probe discrimination in the exonuclease assay. For the UTS2D promoter region, sequence data from six RES and nine SUS identified 10 SNPs (Table 2) , with three SNPs affecting four potential transcription factor binding sites. The C/G SNP at 13,177,951 bp affects a binding site for MLTF-HMG Co Ared transcription factor, a negative regulator of cholesterol biosynthesis (Osborne et al., 1987) . The C/T SNP at 13,177,542 bp affects overlapping sites for (i) c-fos SRE, a serum response factor associated with cell proliferation, differentiation and survival (Gauthier-Rouvière et al., 1990) , and (ii) GR-MT IIA, a glucocorticoid receptor responsible for chondrocyte activity (Karin et al., 1984) . The T/G SNP at 13,177,470 bp is in a site for IRF2 a transcription factor that regulates cell growth (Tanaka et al., 1993; Fujii et al., 1999) . Evaluation of the upstream regions of UTS2D in mouse and human suggested only the IRF2-binding site appears in those mammalian promoter regions in a comparable position, implying that this binding site might function in regulating this gene in all three species. We therefore developed genotyping assays for this SNP (UTS2Dp1, Table 1 ). For AGTR1 we targeted an intron 1 region containing 5 SNPs in a 13 base span (AGTR1i1; Table 1 ). Sequences for this region from 12 DNAs had identified only two haplotypes for the 5 SNPs (Burks, 2011) . We also developed a SNP assay (s13.193, Table 1) for the G/A SNP at 13,193,937 bp. This SNP had shown the most statistical deviation in our original GWAS analyses that identified this region as associated with ascites in females in an F 2 double reciprocal cross of our RES and SUS lines (Krishnamoorthy et al., 2014) . This particular SNP was therefore reasonably a strong candidate for detecting association with ascites for this region in additional lines. In the original 3k SNP panel this SNP was designated as snp-41-245-53961-S-2 (Muir et al., (Table 1) . Genotype frequencies (Freq) were determined for the entire line (All) or for the ascites resistant (R) or susceptible (S) subpopulations based on phenotype in a hypobaric challenge. The total number of genotypes (Count) 2008). The exonuclease assays we designed were then used to genotype the same collection of DNAs from our ascites experimental lines (SUS, RES, and REL) and three commercial lines used in our previous VNTR genotype study (Krishnamoorthy et al., 2014) . DNA samples from REL line and commercial lines W, Y and Z, were from birds phenotyped for ascites resistance or susceptibility using the hypobaric chamber challenge. Analysis of the genotypes for AGTR1i1 in REL showed no significant deviation from HW equilibrium including expected and observed heterozygosity (Table 3 ). In the experimental RES and SUS lines, significant deviation from HW was observed because of high homozygosity for both alleles for this locus. In SUS line, allele 2 was observed at 96% for 51 samples, so statistical deviations were mainly in the differences observed for the infrequent heterozygotes and homozygous allele 1. In the RES, we observed nearly equal numbers of homozygotes for both alleles, but only 7% heterozygotes suggesting that there is a null allele in this populations. We have no explanation for the near absence of heterozygotes in the RES. However, sequence analysis of multiple PCR products from the genotype assays failed to identify any null alleles and confirmed the genotypes observed. The genotype data for REL were consistent with HW which further supports the validity of the genotype assay. Accepting that the analysis in RES and SUS may have some as yet unexplained artifact, at face value we would conclude that selection for susceptibility has dramatically increased the frequency of allele 2 in the SUS. However, allele and genotypic frequencies for AGTR1i1 showed no association with resistance or susceptible phenotype in the REL line chickens for both or either gender (Table 3) .
Data from UTS2Dp1 conformed with HW for the REL, SUS, and RES lines. Allele 2 was the major allele more so in the RES and REL lines than in the SUS line, suggesting a shift in allele frequency with selection of the SUS (Table 3) . However, we did not see any significant association of any particular genotype with ascites phenotype in the REL (Table 3) . Allele 1 is a minor allele (7.5%) in the REL. The low genetic diversity at this locus in REL may preclude detecting any association.
For UTS2Di3, the genotypes for RES, SUS and REL lines conformed with HW equilibrium. In RES line birds, allele 1 was the major allele at 69%. For SUS and REL, allele 1 and 2 were nearly equal in frequency. Selection for ascites resistance was associated with an increase in allele 1 in RES line birds (Table 3) . Analysis of ascites phenotype showed no association in males in REL. Allele 1 was 49% in resistant females and 36% in susceptible females in REL, but was not significantly different (P = 0.160). No specific genotype showed statistical deviation (Table 3) .
The SNP genotypes at locus s13.193 conformed with HW equilibrium for SUS and REL lines but the RES line genotypes were reduced for heterozygotes (observed = 21% vs. expected 32%) with concomitant increases in both homozygotes (Table 3) . Allele 2 was the major allele in REL (84%) and RES (80.5%) but was the minor allele in SUS (3%). This suggests a predominant shift to allele 1 with selection for susceptibility. However, evaluation within the REL line for phenotype for each gender did not identify any statistical association of ascites phenotype with any genotype for this locus. Table 4 . Genotype data for AGTR1i1for the commercial lines. For each line the SNP genotypes were analyzed by ascites phenotype for All and for each gender. All other column headings and row descriptions are as for Analyses were performed for the four SNP loci in the three commercial elite lines W, Y, and Z, analyzed previously (Krishnamoorthy et al., 2014) . For AGTR1i1, lines W, Y, and Z conformed with HW equilibrium (Table 4) . Allele 2 was the major allele in lines W, Y, and Z at 84.5%, 63.5%, and 65.5% respectively. Allele and genotype counts for resistant or susceptible phenotypes were not statistically different from expected for any line or for either gender within the line (Table 4) .
For the UTS2Dp1 locus, the genotypes conformed with HW equilibrium for commercial line Y, but not for line Z due to high allelic homozygosity. Line W was homozygous for allele 2 (Table 5) . Allele 2 was the major allele at 100% in line W, 92.5% in line Y and 67% in line Z, similar to the ascites experimental lines. There was no statistical correlation for any genotype with phenotype for either gender in any of the three commercial lines for this locus.
For the three commercial lines, the genotypes for the UTS2Di3 locus conformed with HW equilibrium only in line Y, but not in lines W (low homozygosity) and Z (high homozygosity). Allele 1 was the major allele in line W (71%), while for lines Y and Z both alleles were nearly equal in frequency (Table 6 ). There were no statistical associations with any allele, or genotype, for either gender with respect to ascites phenotype.
The genotypes for s13.193 did not conform with HW equilibrium in any of the three commercial lines due to an over-abundance of homozygotes for both alleles. Allele 1 was the major allele in lines W (61.5%) and Z (70%), while in line Y both alleles were nearly equal in frequency (Table 7) . Again, we saw no statistical association with respect to ascites phenotype for either gender in any of the three commercial lines for this locus (Table 7) .
Next, we determined the linkage of the specific alleles for AGTR1, UTS2D promoter, UTS2D intron 3, and s13.193 SNP alleles for further ascites association analyses. We imputed haplotypes for each pair of loci where possible (when one or both loci are homozygous) as we had performed previously for VNTR loci (Krishnamoorthy et al., 2014) . Each of the four possible haplotypes (11, 12, 21, 22) was then analyzed for association with ascites in the REL, and the three commercial lines. There were no associations with ascites phenotype observed for either gender for any haplotypes for AGTR1i1 + UTS2Dp1 (Table S1 ), AGTR1i1 + UTS2Di3 (Table S2) , AGTR1i1 + s13.193 (Table S3) , UTS2Dp1 + UTS2Di3 (Table S4) , UTS2Dp1 + s13.193 (Table S5) , or UTS2Di3 + s13.193 (Table S6 ). In our previous analyses of this chromosome 9 region using VNTRs, the B allele, and combined PHS009-PHS010 haplotype BB showed association with ascites resistance in commercial line Y. For line Z there was association with resistance for the PHS009 FF genotype, the PHS010 BB genotype, and the PHS009-PHS010 FB haplotype. Therefore, we aimed to determine whether the SNP genotypes for the two candidate genes further refined VNTR genotypes with respect to ascites. For this, first, we estimated LD for the two VNTRs with each of the four SNP loci in the two commercial lines Y and Z where the VNTRs showed association with ascites, and in the experimental REL line. Our analysis indicated that the SNP loci of AGTR1i1, UTS2Dp1, and UTS2Di3 were in LD with both PHS009 and PHS010 in the REL, Y, and Z lines (D' > 0.5; Table 8 ). However, s13.193 did not show LD for any of the VNTRs in the three lines, except for PHS010 in REL at D' > 0.5 level (Table 8) . Second, we examined the distribution of SNP genotypes with respect to ascites phenotype Table 8 . Estimation of linkage disequilibrium between pairs of VNTR loci (PHS009 and PHS010) and SNP loci (AGTR1i1, UTS2Dp1, UTS2Di3, and s13.193) in experimental REL line, and commercial lines Y and Z. The reported values are Lewontin's normalized disequilibrium co-efficient D (Lewontin, 1964) modified for multiple alleles (Hedrick, 1987) . Values were calculated for the alleles in each of VNTR and SNP locus pair in the three lines. N = sample size in each population; n = number of VNTR alleles in that line. for the specific VNTR genotypes that had previously shown association with resistance. These analyses examined SNP genotypes for the PHS009 and PHS010 BB genotypes birds in line Y, and the PHS009 FF genotype and PHS010 BB genotype birds for line Z. However, we did not observe a significant association with ascites for any SNP genotypes (P < 0.05) for any of the four SNP loci within these specific VNTR genotypes (data not shown). Third, we tabulated SNP haplotypes for pairs of SNP loci with respect to the same VNTR genotypes in line Y, and line Z. Again no significant association was observed for any of these haplotypes with ascites (Tables S7 and S8) .
DISCUSSION
In our previous GWAS study using an F2 cross between SUS and RES lines, a region between 11.8 and 13.6 Mbp on Gga9 was identified as possibly containing a QTL for ascites incidence (Krishnamoorthy et al., 2014) . Using VNTRs we were able to associate the region with ascites in multiple commercial lines, but not in REL line birds. We identified AGTR1 and UTS2D as potential candidate genes in this region that are involved in cardio-pulmonary function, and therefore could mediate the disease phenotype. Moreover, these two genes represent the extremes of the chromosomal region (AGTR1 at 11.8 Mbp, and UTS2D at 13.2 Mbp). The present study, therefore, employs SNP loci spanning the region to determine which, if any, of the candidate genes are more closely linked to the ascites QTL. Remarkably, genotype data for SNP assays for AGTR1 and UTS2D did not show any significant association in the REL or any of the three commercial lines previously determined in Krishnamoorthy et al. (2014) . The SNP assays spanned the region from 11.86 to 13.19 Mbp, whereas the VNTR assays had targeted 11.81 and 11.93 Mbp. None of the SNP assays showed any statistical association even in commercial line Y which had shown the strongest association using VNTRs in Krishnamoorthy et al. (2014) . Line Y is the modern descendant from what was the original source from which the SUS, REL, and RES lines were originally derived (Pavlidis et al., 2007) .
In our current study, all SNP loci conformed with HW equilibrium in REL. AGTR1i1 and UTS2Dp1 conformed with HW in two of the three commercial lines. Failure to conform with HW in most of the commercial lines, led us to question the reliability of the assays for the UTS2Di3 and s13.193 loci. Sequence data from 10 to 16 PCR products representing different genotypes for each of the loci corroborated the exonuclease-based SNP genotypes, indicating that our assays were reliable. Therefore, the error rate of genotype mis-calls appears fairly low.
We used Hedrick's multiallelic extension of Lewontin's standardized D' to examine LD between the SNP and VNTR loci (Lewontin, 1964; Hedrick, 1987) . For biallelic markers, D' > 0.33 has been posited to indicate loci in LD (Abecasis et al., 2001) , while others have suggested that LD is indicated only when D' is greater than 0.5 (Reich et al., 2001) . D' > 0.3 has been used as threshold for useful measure of LD between SNP and VNTR loci (Schulze et al., 2002) . In our study, comparison of the AGTR1i1, UTS2Dp1, and UTS2Di3 SNP loci with VNTR loci in REL, Y, and Z lines manifested D' values greater than 0.5, suggesting that the SNP and microsatellite loci were in LD in the given lines. However, s.13.193 was generally in much lower LD for the VNTRs in most of the lines ( Table 8 ). Given that these loci occur within a region spanning approximately 1.4 Mbp on chromosome 9, we would have expected higher LD for all the SNP loci, including s13.193. For AGTR1i1 and UTS2Dp1, we could identify a SNP allele that was predominantly associated with particular VNTR alleles that had previously shown association. AGTR1i1 allele 2, and UTS2Dp1 allele 2 were overwhelmingly associated with the BB genotype for PHS009-010 in line Y, and FF and BB genotypes for PHS009 and PHS010 respectively in line Z. Even though those VNTR genotypes were associated with ascites resistance, the corresponding SNP alleles or the combined SNP haplotype did not show any association with ascites resistance in the tested commercial lines.
Since the UTS2Dp1 probes are for SNPs that affect an IRF2 binding site, we have pursued an allele specific expression assay targeting the 3 -UTR. We PCR amplified and sequenced the 615 bp long 3 -UTR (13184523-13185137 bps) for UTS2D from DNA samples for five heterozygotes and two homozygotes for UTS2Dp1 (based on qPCR and verified by PCR sequencing). We identified five SNPs in the 3 -UTR. Both UTS2Dp1 homozygotes were heterozygous for all five SNPs, while only one UTS2Dp1 heterozygote was heterozygous for these five SNPs. When we included the UTS2Di3 genotypes, from these seven DNAs we identified five different combined (UTS2Dp1-UTS2Di3-3 UTR) genotype patterns (211, 221, 232, 322, and 332) which would require a minimum of five distinct alleles to produce these five patterns. Therefore, although we chose apparently biallelic SNP regions for our exonuclease genotype assays, each of those alleles may have a number of subtypes based on SNPs in flanking regions. This is evidenced by the number of haplotypes we impute for the three SNP positions we investigated here, despite the three SNP regions spanning only 7,700 bases on chromosome 9. It is quite likely that s13.193 (which is 21 kb 3' to UTS2D) is also affected by the same diversity of alleles. The presence of the subtypes of SNP alleles could also explain why the UTS2D promoter and s13.193 do not conform with HW equilibrium in some of the tested lines. Therefore, our current study suggests that apparently there is no association of the AGTR1 and UTS2D polymorphisms/haplotypes with ascites, so we are unable to ascribe any QTL function to a specific candidate gene or gene polymorphism for this region of Gga9 based on SNP genotypes. Our data are most consistent with high rates of recombination events within this region that reassort the SNP loci generating multiple haplotypes and compromising LD across a small chromosomal region. Thus, it is not a simple task to develop a useful genetic test for marker assisted selection for this region. We selected common SNPs whose alleles represented approximately 50% frequency in REL for our investigations, and it may be that less frequent SNPs would be more diagnostic. Combining SNPs into haplotypes using 10 or more SNPS might also identify particular chromosomal segments associated with ascites. Subsequent GWAS on REL line samples have failed to show any association for ascites with this region on Gga9 but have identified regions on chromosomes 2 and Z (Tarrant et al., in review). Nonetheless, because the region on Gga9 showed association in an experimental cross, and VNTR data showed an association in some commercial lines as described in Krishnamoorthy et al. (2014) , this region may still have limited utility for further investigations of ascites susceptibility. Although our study does not support association of the polymorphisms in the two genes with ascites phenotype, AGTR1 and UTS2D still remain candidates for future investigation of relevance in this disease. This work is one of the first to have investigated the association of these two gene polymorphisms with ascites phenotype in broilers. Our null findings provide important clues and cautions for future studies involving the genes contributing to ascites. Future studies may need to account for environmental and epistatic effects, as well as perform genome wide studies to identify additional candidate gene regions for ascites phenotype. Table S1 . Haplotype data combining AGTR1i1 and UTS2Dp1 genotypes for the REL and commercial lines. Haplotypes were imputed where possible, as described in materials and methods. Column and row designations are as for Tables 3 and 4.  Table S2 . Haplotype data combining AGTR1i1 and UTS2Di3 genotypes for the REL and commercial lines. Haplotypes were imputed where possible, as described in materials and methods. Column and row designations are as for Tables 3 and 4.  Table S3 . Haplotype data combining AGTR1i1 and s13.193 genotypes for the REL and commercial lines. Haplotypes were imputed where possible, as described in materials and methods. Column and row designations are as for Tables 3 and 4.  Table S4 . Haplotype data combining UTS2Dp1 and UTS2Di3 genotypes for the REL and commercial lines. Haplotypes were imputed where possible, as described in materials and methods. Column and row designations are as for Tables 3 and 4 . Tables 3 and 4.  Table S6 . Haplotype data combining UTS2Di3 and s13.193 genotypes for the REL and commercial lines. Haplotypes were imputed where possible, as described in materials and methods. Column and row designations are as for Tables 3 and 4.  Table S7 . SNP haplotype data for PHS009-PHS010 BB genotype in commercial line Y. Haplotypes were imputed where possible, as described in materials and methods. Column and row designations are as for Tables 3 and 4. Table S8 . SNP haplotype data for PHS009 (FF genotype) and PHS010 (BB genotype) in commercial line Z. Haplotypes were imputed, where possible, as described in materials and methods. Column and row designations are as for Tables 3 and 4. Supplementary data are available at PSCIEN online.
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